Still learning about this company. Up 10% on Friday and has doubled in value from 11 Jun - so thought would post in the hope of getting Straw insights on this stock as does have a lot of coverage ATM.

Announcement of 1 Jul notes:

• $13M FY24 sales revenue, up 80% vs PCP,
• $3.8M Q4 sales FY24 up 88% vs PCP
• Third consecutive qtr of positive cash flow and second consecutive qtr of positive EBITDA for Q4FY24.

BIO develop, licence, commercialise and market innovative, evidenced based probiotics. Many of their products are supported by clinical trials. Marketing strategy seems to start with self designated practitioner only sales through health care professionals, then expands into behind the counter sales. Strategy seems to be working - positions the product as superior to on the shelf competition. In Australia and recently launched into the UK/Ireland - so is it time to hop on board?

Market Cap - $135.5M, SOI 215M. SP currently at 52 week high at 63c with 52 week low of 7.5c on 4 July 23

Strawman would be great if you could interview the CEO ;)

Disclosure - Purchased parcel in RL